Neurodevelopmental Disorders Discussion Post
Description
DQ#1 Neurodevelopmental Disorders
Save your time - order a paper!
Get your paper written from scratch within the tight deadline. Our service is a reliable solution to all your troubles. Place an order on any task and we will take care of it. You won’t have to worry about the quality and deadlines
Order Paper Now- Discuss in detail two disorders listed under the Neurodevelopmental Disorders section of the DSM 5.
- According the DSM 5 and the unit readings, please explain the pattern of familial heritage being closely associated to autism.
- As a future counselor would you work effectively with the Neurodevelopmental Disorders? Please be specific in identifying why or why not.
DQ#2 Trauma and Stressor Related Disorders
- Discuss the biopsychosocial perspective on trauma and stressor related disorders.
- Select one trauma and stressor related disorder (e.g. PTSD, reactive attachment disorder, acute stress disorder, etc.) and detail the symptoms, causes and treatment for that disorder.
- Identify and discuss at least one ethical consideration when working with a client who has experiences a trauma or significant stressor.
DQ#3 Anxiety and Obsessive Compulsive Disorders
- Select one anxiety disorder found in the DSM 5 and unit readings and then describe in detail the characteristics of that disorder. Include in your response effective treatment modalities for the anxiety disorder selected.
- Select one obsessive-compulsive and related disorder that you are most unfamiliar with and explain the symptoms, causes and treatment for that disorder.
- Additionally, what are the ethical considerations for a counselor working in a client’s home when the client is diagnosed with agoraphobia?
UNFORMATTED ATTACHMENT PREVIEW
NOVEMBER 2015 THE BROWN UNIVERSITY CHILD & ADOLESCENT PSYCHOPHARMACOLOGY UPDATE ful for clinicians and families to know about “side effects that wane with prolonged treatment,” they write. Another limitation was the heterogeneity of the population in this study compared to the Pediatric ADHD Treatment Study and POTS studies. Finally, the period of observation and assessment may have been too brief to evaluate side effects in the SSRI class. 3 However, this important study looks at a problem that has been recognized for more than 15 years in the pediatric and psychiatric community, the researchers concluded. The positive note is the affirmation of melatonin as a well-tolerated option for very young children, at least on a short-term basis. More studies are needed to further examine the types and frequencies of AEs related to the use of psychotropic medications in very young children, the researchers concluded. ▪ An expert steering